Ocular Therapeutix (OCUL) Receivables: 2013-2025
Historic Receivables for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $30.8 million.
- Ocular Therapeutix's Receivables rose 1.76% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.8 million, marking a year-over-year increase of 4.94%. This contributed to the annual value of $32.4 million for FY2024, which is 23.72% up from last year.
- Latest data reveals that Ocular Therapeutix reported Receivables of $30.8 million as of Q3 2025, which was up 1.17% from $30.4 million recorded in Q2 2025.
- Ocular Therapeutix's 5-year Receivables high stood at $32.4 million for Q4 2024, and its period low was $13.6 million during Q1 2021.
- Moreover, its 3-year median value for Receivables was $27.3 million (2023), whereas its average is $27.6 million.
- As far as peak fluctuations go, Ocular Therapeutix's Receivables surged by 551.84% in 2021, and later dropped by 8.98% in 2023.
- Ocular Therapeutix's Receivables (Quarterly) stood at $21.1 million in 2021, then rose by 0.90% to $21.3 million in 2022, then grew by 22.76% to $26.2 million in 2023, then rose by 23.72% to $32.4 million in 2024, then rose by 1.76% to $30.8 million in 2025.
- Its Receivables stands at $30.8 million for Q3 2025, versus $30.4 million for Q2 2025 and $25.2 million for Q1 2025.